10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001683168-20-003871`
Period End Date	20200930
Filing Date	20201112
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	xbio-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 55 Income Statement 64 Cash Flow Statement 68 Stockholders Equity 38

Balance Sheet 55 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	12.50M	shares	Point-in-time
Cash	`Cash`	$7.05M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.09M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	6.32M	shares	Point-in-time
Cash	`Cash`	$10.37M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$937.60K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$722.08K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	6.07M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	6.30M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.09M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.99M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$757.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.21M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$704.43K	USD	Point-in-time
Total assets	`Assets`	$8.70M	USD	Point-in-time
Total assets	`Assets`	$21.55M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$931.13K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$251.03K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$484.03K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$537.44K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$788.47K	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$4.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$788.47K	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of September 30, 2020 and December 31, 2019; 6,323,218 and 6,092,432 shares issued as of September 30, 2020 and December 31, 2019, respectively; 6,296,227 and 6,065,441 shares outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$6.09K	USD	Point-in-time
Common stock, $0.001 par value; 12,500,000 shares authorized as of September 30, 2020 and December 31, 2019; 6,323,218 and 6,092,432 shares issued as of September 30, 2020 and December 31, 2019, respectively; 6,296,227 and 6,065,441 shares outstanding as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$6.32K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$188.63M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$188.24M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-166.01M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-175.70M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.39M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.36M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$17.21M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$18.26M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.91M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.70M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.55M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	-	USD	3 Qtrs
Total revenues	`Revenues`	$115.93K	USD	1 Quarter
Total revenues	`Revenues`	$285.61K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.52M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.24M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$573.06K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.47M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$804.15K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.14M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.90M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.52M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	$9.24M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	$3.28M	USD	1 Quarter
Asset impairment charges	`AssetImpairmentCharges`	$9.24M	USD	1 Quarter
Asset impairment charges	`AssetImpairmentCharges`	$3.28M	USD	3 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$13.00M	USD	3 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$11.65M	USD	3 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$8.95M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$10.62M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-11.65M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-10.50M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-8.95M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-12.72M	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$267.00	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$585.00	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$643.00	USD	3 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-223.00	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$24.93K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$105.04K	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$46.93K	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$46.62K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$105.69K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$47.20K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$25.52K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$46.39K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.48M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-12.61M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-11.60M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.90M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$2.92M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$2.92M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-7.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.60M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.69M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.90M	USD	1 Quarter
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$1.40M	USD	1 Quarter
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	3 Qtrs
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
Deemed dividend	`PreferredStockDividendsIncomeStatementImpact`	$5.28M	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.89M	USD	3 Qtrs
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.31M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.56M	USD	1 Quarter
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.69M	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-9.07	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-2.67	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-1.20	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-1.55	USD	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.86M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.30M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.27M	shares	3 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.86M	shares	3 Qtrs

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-7.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.60M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.69M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.90M	USD	1 Quarter
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	-	USD	3 Qtrs
Acquired in-process research and development	`ResearchAndDevelopmentInProcess`	$3.03M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	$9.24M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentCharges`	$3.28M	USD	1 Quarter
Asset impairment charges	`AssetImpairmentCharges`	$9.24M	USD	1 Quarter
Asset impairment charges	`AssetImpairmentCharges`	$3.28M	USD	3 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	-	USD	3 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$2.92M	USD	3 Qtrs
Depreciation	`Depreciation`	-	USD	1 Quarter
Depreciation	`Depreciation`	$757.00	USD	3 Qtrs
Depreciation	`Depreciation`	$1.00K	USD	1 Quarter
Depreciation	`Depreciation`	$3.37K	USD	3 Qtrs
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$16.63K	USD	3 Qtrs
Amortization of right of use asset	`OtherDepreciationAndAmortization`	$20.04K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$2.00K	USD	3 Qtrs
Gain on settlement with vendor	`GainsLossesOnExtinguishmentOfDebt`	$143.64K	USD	3 Qtrs
Gain on settlement with vendor	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Share-based expense	`ShareBasedCompensation`	$683.10K	USD	3 Qtrs
Share-based expense	`ShareBasedCompensation`	$388.13K	USD	3 Qtrs
Issuance of warrants in connection with reverse stock split	`IssuanceOfWarrantsInConnectionWithReverseStockSplit`	-	USD	3 Qtrs
Issuance of warrants in connection with reverse stock split	`IssuanceOfWarrantsInConnectionWithReverseStockSplit`	$-63.54K	USD	3 Qtrs
Vendor share-based payments	`VendorShareBasedPayments`	-	USD	3 Qtrs
Vendor share-based payments	`VendorShareBasedPayments`	$47.43K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-273.05K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$297.71K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-483.05K	USD	3 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$54.17K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.31M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.72M	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00K	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.00K	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants in July 2019 public offering	`NetProceedsFromIssuanceOfCommonStockAndWarrants`	-	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants in July 2019 public offering	`NetProceedsFromIssuanceOfCommonStockAndWarrants`	$13.42M	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants in March 2019 registered direct offering	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants in March 2019 registered direct offering	`ProceedsFromIssuanceOrSaleOfEquity`	$2.70M	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$5.01K	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.13M	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-3.31M	USD	3 Qtrs
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$11.41M	USD	3 Qtrs
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.05M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.04M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.05M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.04M	USD	Point-in-time
Cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.37M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$8.00	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Right of use assets obtained in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	3 Qtrs
Right of use assets obtained in exchange for lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$43.33K	USD	3 Qtrs
Issuance of common stock to vendor	`IssuanceOfCommonStockToVendor`	$1.00	USD	3 Qtrs
Issuance of common stock to vendor	`IssuanceOfCommonStockToVendor`	$7.00	USD	3 Qtrs
Issuance of common stock to acquire in-process research and development	`IssuanceOfCommonStockToAcquireInprocessResearchAndDevelopment`	$3.03M	USD	3 Qtrs
Issuance of common stock to acquire in-process research and development	`IssuanceOfCommonStockToAcquireInprocessResearchAndDevelopment`	-	USD	3 Qtrs
Issuance of common stock to adjust for Reverse Stock Split	`IssuanceOfCommonStockToAdjustForReverseStockSplit`	-	USD	3 Qtrs
Issuance of common stock to adjust for Reverse Stock Split	`IssuanceOfCommonStockToAdjustForReverseStockSplit`	$1.00	USD	3 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$1.89K	USD	3 Qtrs
Issuance of common stock from cashless exercise of purchase warrants	`IssuanceOfCommonStockFromCashlessExerciseOfPurchaseWarrants`	$229.00	USD	3 Qtrs

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$10.39M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$7.91M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$15.36M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$18.26M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Issuance of common stock and warrants in registered direct offering, net of issuance costs, value	`IssuanceOfCommonStockAndWarrantsInMarch2019RegisteredDirectOfferingNetOfIssuanceCostsValue`	$2.70M	USD	3 Qtrs
Issuance of common stock and warrants in July 2019 public offering, net of issuance costs, value	`IssuanceOfCommonStockAndWarrantsInPublicOfferingNetOfIssuanceCostsValue`	$13.42M	USD	3 Qtrs
Issuance of common stock and warrants in July 2019 public offering, net of issuance costs, value	`IssuanceOfCommonStockAndWarrantsInPublicOfferingNetOfIssuanceCostsValue`	$13.42M	USD	1 Quarter
Issuance of common stock in connection with purchase of in-process research and development, value	`IssuanceOfCommonStockInConnectionWithPurchaseOfInprocessResearchAndDevelopmentValue`	$3.03M	USD	1 Quarter
Issuance of common stock in connection with purchase of in-process research and development, value	`IssuanceOfCommonStockInConnectionWithPurchaseOfInprocessResearchAndDevelopmentValue`	$3.03M	USD	3 Qtrs
Exercise of pre-funded warrants, value	`ExerciseOfPrefundedWarrantsValue`	$4.50K	USD	1 Quarter
Exercise of pre-funded warrants, value	`ExerciseOfPrefundedWarrantsValue`	$5.01K	USD	3 Qtrs
Exercise of purchase warrants, value	`ExerciseOfPurchaseWarrantsValue`	-	USD	3 Qtrs
Exercise of purchase warrants, value	`ExerciseOfPurchaseWarrantsValue`	-	USD	1 Quarter
Issuance of common stock to vendor, value	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	3 Qtrs
Issuance of warrants in connection with reverse stock split, value	`IssuanceOfWarrantsInConnectionWithReverseStockSplitValue`	$63.54K	USD	1 Quarter
Issuance of warrants in connection with reverse stock split, value	`IssuanceOfWarrantsInConnectionWithReverseStockSplitValue`	$63.54K	USD	3 Qtrs
Deemed dividend related to Series B Preferred Stock down round provision	`DeemedDividendRelatedToSeriesBPreferredStockDownRoundProvision`	$5.28M	USD	3 Qtrs
Deemed dividend related to Series B Preferred Stock down round provision	`DeemedDividendRelatedToSeriesBPreferredStockDownRoundProvision`	$1.40M	USD	1 Quarter
Accretion of deemed dividend related to Series B Preferred Stock down round provision	`OtherPreferredStockDividendsAndAdjustments`	$5.28M	USD	3 Qtrs
Accretion of deemed dividend related to Series B Preferred Stock down round provision	`OtherPreferredStockDividendsAndAdjustments`	$1.40M	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$388.13K	USD	3 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$232.44K	USD	1 Quarter
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$683.10K	USD	3 Qtrs
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$110.80K	USD	1 Quarter
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$47.43K	USD	3 Qtrs
Common stock awards to vendors	`AdjustmentsToAdditionalPaidInCapitalOther`	$15.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.56M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.60M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.69M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.90M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$10.39M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$7.91M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$15.36M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$17.21M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$18.26M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.